First Analysis
http://www.firstanalysis.com/index.asp?PID=16First Analysis is an investment organization specializing in private equity, venture capital, investment banking, and equity research. The sectors in the firm’s coverage universe include outsourced services, IT products and services, and chemistry-enabled businesses. First Analysis was founded in 1981.
View Older Stories View More Recent Stories
-
Pluralsight (PS) Prices 13.558M Share Follow-Offering by Selling Shareholders at $29.25/Sh
-
Pluralsight, Inc. Announces Pricing of Follow-On Offering by Selling Stockholders
-
Pluralsight, Inc. Announces Pricing of Follow-On Offering by Selling Stockholders
-
Tabula Rasa HealthCare (TRHC) Reports Acquisition of PrescribeWellness
-
Tabula Rasa HealthCare Announces Acquisition of PrescribeWellness Expanding its Medication Risk Mitigation Offering
-
Tabula Rasa HealthCare Announces Acquisition of PrescribeWellness Expanding its Medication Risk Mitigation Offering
-
Pluralsight (PS) Announces Proposed 13.56M Share Follow-On Offering by Selling Stockholders
-
Pluralsight, Inc. Announces Proposed Follow-On Offering by Selling Stockholders
-
Pluralsight, Inc. Announces Proposed Follow-On Offering by Selling Stockholders
-
Benefitfocus (BNFT) Prices 5.7M Secondary Offering of Common Stock at $48.25/Share
-
Benefitfocus Announces Pricing of Secondary Offering
-
Benefitfocus Announces Pricing of Secondary Offering
-
First Analysis Downgrades ORBCOMM (ORBC) to Outperform
-
Benefitfocus (BNFT) Announces 5.7M Share Secondary Offering of Common Stock
-
Benefitfocus Announces Secondary Offering
-
Benefitfocus Announces Secondary Offering
-
First Analysis Downgrades Sierra Wireless (SWIR) to Neutral
-
First Analysis Upgrades Fortinet (FTNT) to Outperform
-
First Analysis Starts EVO Payments (EVOP) at Outperform
-
Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
-
Casella Waste Systems Announces Closing of Public Offering of Class A Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Casella Waste Systems (CWST) Prices 3.1M Class A Share Offering at $29.50/Sh
-
Casella Waste Systems Announces Pricing of Public Offering of 3,100,000 Shares of Class a Common Stock
-
First Analysis Upgrades Codexis, Inc. (CDXS) to Outperform
-
First Analysis of European Anti-Fraud Efforts Shows 94 Percent Fraud Reduction in TAG Certified Channels
-
First Analysis Downgrades CalAmp Corp. (CAMP) to Outperform
-
Daiichi Sankyo Presents Updated Phase 1 Results of [Fam-] Trastuzumab Deruxtecan (DS-8201) in Patients with HER2 Low Expressing Metastatic Breast Cancer at 2018 San Antonio Breast Cancer Symposium (SA
-
Myriad Genetics (MYGN) Highlights Study on First Prospective Outcomes Data on EndoPredict for Women with Early-Stage Breast Cancer at San Antonio Breast Cancer Symposium
-
Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer
-
Prospective Study Demonstrates EndoPredict® Can Guide Chemotherapy Decision For Women with Early-Stage Breast Cancer
-
First Analysis Downgrades SecureWorks (SCWX) to Neutral
-
Zogenix Presents Positive Findings on the Impact of Treatment with FINTEPLA® (ZX008) on Everyday Executive Function in Patients with Dravet Syndrome
-
First Analysis Upgrades Palo Alto Networks (PANW) to Outperform
-
First Analysis Upgrades Tableau Software (DATA) to Outperform
-
First Analysis Upgrades Bottomline Technologies (EPAy) to Strong Buy
-
First Analysis Upgrades Cambrex Corporation (CBM) to Strong Buy
-
First Analysis Downgrades Sierra Wireless (SWIR) to Outperform
-
First Analysis Upgrades Catalent (CTLT) to Outperform
-
First Analysis Upgrades New Relic (NEWR) to Strong Buy
-
Repligen (RGEN) PT Raised to $75 at First Analysis
-
First Analysis Upgrades HMS Holdings (HMSY) to Outperform
-
Whiteblock completes industry's first EOS benchmark testing and blockchain investigation
-
First Analysis Upgrades Chegg (CHGG) to Outperform
-
First Analysis Upgrades Health Insurance Innovations (HIIQ) to Strong Buy
-
First Analysis Upgrades Neogenomics (NEO) to Strong Buy
-
Higher Delivered Dose of Tumor Treating Fields to Tumor Bed Associated with Improved Overall Survival in Newly Diagnosed Glioblastoma
-
First Analysis Downgrades SendGrid (SEND) to Outperform
-
First Analysis Upgrades Alarm.com (ALRM) to Strong Buy
-
Delcath Systems (DCTH) Reports Publication of Multi-Center Analysis of Outcomes Data on Use of CHEMOSAT
-
Multi-center Analysis of Outcomes Data on Use of Delcath CHEMOSAT in the Treatment of ICC Published in European Radiology


